Market Overview:
The global molecular diagnostics market reached a value of US$ 17.22 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 27.19 Billion by 2027, exhibiting a CAGR of 7.70% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Molecular diagnostics refers to a set of laboratory tests that sequences the deoxyribonucleic acid (DNA), ribonucleic acid (RNA), or cell proteins of an individual to analyze biomarkers of potential diseases. It assists in diagnosing and monitoring infections and diseases, detecting risks, and assessing therapy response. In recent years, molecular diagnostics has rapidly gained traction in oncology, pharmacogenomics, microbiology, infectious diseases, genetic disease screening, and blood screening. With recent advancements, molecular diagnostics has become an essential aspect of patient-tailored interventions and therapeutics, which is escalating its demand across the globe.
Molecular Diagnostics Market Trends:
Molecular diagnostics is widely used by hospitals, laboratories, and research institutes for early detection of diseases, coagulation, and human leukocyte antigen typing. As a result, the rising prevalence of chronic conditions, such as cancer, cardiovascular diseases (CVDs), neurological disorders, and infectious diseases, represents the primary factor driving the market growth. Besides this, the growing geriatric population that is more susceptible to developing numerous medical ailments and the widespread adoption of point-of-care (POC) testing devices are catalyzing the product demand. Additionally, the recent outbreak of coronavirus disease (COVID-19) has accelerated the adoption of molecular diagnostic methods, such as polymerase chain reaction (PCR), for COVID-19 testing. Along with this, several favorable initiatives undertaken by the governing agencies and regulatory authorities of various countries, such as fast approvals of diagnostic products to help curb the spread of the virus, are also propelling the market growth. Furthermore, the leading players are making heavy investments to launch innovative diagnostic devices that offer enhanced accuracy, flexibility, cost-effectiveness, and faster results to expand their product portfolio and gain a competitive edge. Other factors, including the escalating demand for personalized treatment, the emerging trend of preventive medicine, improving healthcare infrastructure, and technological advancements, are also creating a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular diagnostics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, technology, application and end users.
Breakup by Product:
- Reagents and Kits
- Instruments
- Software and Services
Breakup by Technology:
- Polymerase Chain Reactions (PCR)
- Hybridization
- DNA Sequencing
- Microarray
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Others
Breakup by Application:
- Infectious Diseases Diagnostics
- Oncology
- Genetic Testing
- Blood Screening
- Others
Breakup by End Users:
- Hospitals
- Laboratories
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin Molecular LLC (DiaSorin), F. Hoffmann-La Roche AG (Roche Holding AG), Hologic Inc., Illumina Inc., Myriad Genetics Inc., Qiagen, Quidel Corporation and Thermo Fisher Scientific.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Product, Technology, Application, End Users, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Diasorin Molecular LLC (DiaSorin), F. Hoffmann-La Roche AG (Roche Holding AG), Hologic Inc., Illumina Inc., Myriad Genetics Inc., Qiagen, Quidel Corporation and Thermo Fisher Scientific. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global molecular diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global molecular diagnostics market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end users?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global molecular diagnostics market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Molecular Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Reagents and Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Software and Services
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Technology
7.1 Polymerase Chain Reactions (PCR)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hybridization
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 DNA Sequencing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Microarray
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Application
8.1 Infectious Diseases Diagnostics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oncology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Genetic Testing
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Blood Screening
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End Users
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Becton Dickinson and Company
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Biomerieux SA
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Danaher Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Diasorin Molecular LLC (DiaSorin S.p.A.)
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 F. Hoffmann-La Roche AG (Roche Holding AG)
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 SWOT Analysis
15.3.8 Hologic Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Illumina Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Myriad Genetics Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Qiagen
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Quidel Corporation
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 Thermo Fisher Scientific
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
15.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Molecular Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Molecular Diagnostics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Molecular Diagnostics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Molecular Diagnostics Market: Breakup by Product (in %), 2021
Figure 5: Global: Molecular Diagnostics Market: Breakup by Technology (in %), 2021
Figure 6: Global: Molecular Diagnostics Market: Breakup by Application (in %), 2021
Figure 7: Global: Molecular Diagnostics Market: Breakup by End Users (in %), 2021
Figure 8: Global: Molecular Diagnostics Market: Breakup by Region (in %), 2021
Figure 9: Global: Molecular Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Molecular Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Molecular Diagnostics (Hybridization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Molecular Diagnostics (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Molecular Diagnostics (Genetic Testing) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Molecular Diagnostics (Genetic Testing) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Molecular Diagnostics (Blood Screening) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Molecular Diagnostics (Blood Screening) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Molecular Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Molecular Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Molecular Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Molecular Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Molecular Diagnostics (Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Molecular Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: North America: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: North America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: United States: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: United States: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Canada: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Canada: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Asia-Pacific: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Asia-Pacific: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: China: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: China: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Japan: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Japan: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: India: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: India: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: South Korea: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: South Korea: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Australia: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Australia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Indonesia: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Indonesia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Europe: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Europe: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Germany: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Germany: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: France: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: France: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: United Kingdom: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: United Kingdom: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Italy: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Italy: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Spain: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Spain: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Russia: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Russia: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Latin America: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Latin America: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Brazil: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Brazil: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Mexico: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Mexico: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Others: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Middle East and Africa: Molecular Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Middle East and Africa: Molecular Diagnostics Market: Breakup by Country (in %), 2021
Figure 91: Middle East and Africa: Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Global: Molecular Diagnostics Industry: SWOT Analysis
Figure 93: Global: Molecular Diagnostics Industry: Value Chain Analysis
Figure 94: Global: Molecular Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Molecular Diagnostics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Molecular Diagnostics Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Molecular Diagnostics Market Forecast: Breakup by End Users (in Million US$), 2022-2027
Table 6: Global: Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Molecular Diagnostics Market: Competitive Structure
Table 8: Global: Molecular Diagnostics Market: Key Players